Skip to main content

Australia to Award A$25M for Genomics Research into Diseases

NEW YORK (GenomeWeb) – The Australian government said today that it plans to award A$25 million (US$19.1 million) to one research team to conduct genomics research to prevent, diagnose, and treat diseases. 

The program, called Targeted Call for Research into Preparing Australia for the Genomics Revolution in Health Care, was announced today by the National Health and Medical Research Council. Under the program, a research team will receive the five-year award for a project that is expected to elucidate the impact of genomic data on patient care and to identify the economic and policy impacts of incorporating such data into the health system. The research resulting from the award is anticipated to help clinicians use genomics to manage diseases, such as cancer and diabetes, NHMRC said. 

"In health care today, we can already see how genomics is making a difference in the diagnosis of some diseases, including certain types of cancers," NHMRC CEO Warwick Anderson said in a statement. "The research conducted through this targeted call for research will yield new knowledge that will help us to understand how best to use the power of genomics to improve patient treatment."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.